severe side effects of semaglutide for diabetes and obesity treatment What are the long-term side
Description
The appeal applies to GLP-1 drugs approved for weight lossliraglutide, semaglutide, and tirzepatideas GLP-1 medications approved solely for type 2 diabetes do not currently include a suicidal ideation and behavior warning.
Consume Protein-Rich Foods Protein promotes GLP-1 secretion, aiding satiety and blood sugar control
Notably, no permanent treatment discontinuations or dose reductions due to gastrointestinal side effects were reported in ribupatide-treated participants
Nevertheless, the overall drug exposure was not considered clinically significant
Life expectancy slightly reduced (complications like infections)
